EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Circulating cell-free DNA-based multi-cancer early detection

Kai Zhang, Ruiqing Fu, Rui Liu, Zhixi Su

Trends in Cancer · 2024-02 · 10 (2) · 161-174

DOI: 10.1016/j.trecan.2023.08.010 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Trends in Cancer, 2024-02. Verfasst von Kai Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cancer Prevention, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Scie…. Hauptthemen laut MEDLINE: Cell-Free Nucleic Acids, Neoplasms. Die Arbeit wurde bisher 80-mal zitiert (Crossref) und nennt 80 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients benefit considerably from early detection of cancer. Existing single-cancer tests have various limitations, which could be effectively addressed by circulating cell-free DNA (cfDNA)-based multi-cancer early detection (MCED). With sensitive detection and accurate localization of multiple cancer types at a very low and fixed false-positive rate (FPR), MCED has great potential to revolutionize early cancer detection. Herein, we review state-of-the-art approaches for cfDNA-based MCED and their limitations and discuss both technical and clinical challenges in the development and application of MCED tests. Given the constant improvements in technology and understanding of cancer biology, we propose that a cfDNA-based targeted sequencing assay that integrates multimodal features should be optimized for MCED.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell-Free Nucleic AcidsNeoplasmsHumansEarly Detection of Cancer

Stichwörter der Autor:innen

DNA methylationcancer screeningcirculating cell-free DNA (cfDNA)fragmentomicsmulti-cancer early detection (MCED)tissue of origin (TOO)

Substanzen

Cell-Free Nucleic Acids

Autor:innen und Institutionen

  • Department of Cancer Prevention, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 17 South Panjiayuan Lane, Chaoy…
  • Singlera Genomics Ltd, Shanghai 201203, China.
  • Singlera Genomics Ltd, Shanghai 201203, China. Electronic address: zhixi.su@singleragenomics.com.

Zitieren

APA

Zhang, K., Fu, R., Liu, R., & Su, Z. (2024). Circulating cell-free DNA-based multi-cancer early detection. Trends in Cancer, 10(2), 161-174. https://doi.org/10.1016/j.trecan.2023.08.010

Vancouver

Zhang K, Fu R, Liu R, Su Z. Circulating cell-free DNA-based multi-cancer early detection. Trends in Cancer. 2024;10(2):161-174. doi:10.1016/j.trecan.2023.08.010

BibTeX
@article{Zhang2024,
  author = {Zhang, Kai and Fu, Ruiqing and Liu, Rui and Su, Zhixi},
  title = {Circulating cell-free DNA-based multi-cancer early detection},
  journal = {Trends in Cancer},
  year = {2024},
  volume = {10},
  number = {2},
  pages = {161--174},
  doi = {10.1016/j.trecan.2023.08.010}
}
Kostenlos starten →